Outset Medical Quarterly Income Statements Chart
Quarterly
|
Annual
Outset Medical Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenue: | |||||||||||||||
| product revenue | 20,428,000 | 22,897,000 | 23,531,000 | 29,330,000 | 27,779,000 | 26,364,000 | 21,739,000 | 19,621,000 | 25,664,000 | 23,650,000 | 21,824,000 | 20,628,000 | 18,210,000 | 13,177,000 | 10,812,000 |
| service and other revenue | 7,740,000 | 7,610,000 | 6,831,000 | 6,710,000 | 5,688,000 | 5,643,000 | 6,022,000 | 5,436,000 | 4,886,000 | 4,502,000 | 4,494,000 | 4,588,000 | 4,706,000 | 4,070,000 | 2,944,000 |
| total revenue | 28,168,000 | 30,507,000 | 30,362,000 | 36,040,000 | 33,467,000 | 32,007,000 | 27,761,000 | 25,057,000 | 30,550,000 | 28,152,000 | 26,318,000 | 25,216,000 | 22,916,000 | 17,247,000 | 13,756,000 |
| yoy | -15.83% | -4.69% | 9.37% | 43.83% | 9.55% | 13.69% | 5.48% | -0.63% | 33.31% | 63.23% | 91.32% | ||||
| qoq | -7.67% | 0.48% | -15.75% | 7.69% | 4.56% | 15.29% | 10.79% | -17.98% | 8.52% | 6.97% | 4.37% | 10.04% | 32.87% | 25.38% | |
| cost of revenue: | |||||||||||||||
| cost of product revenue | 12,581,000 | 14,588,000 | 16,837,000 | 22,212,000 | 20,817,000 | 22,050,000 | 19,632,000 | 17,718,000 | 23,110,000 | 21,459,000 | 20,526,000 | 22,077,000 | 20,577,000 | 14,917,000 | 17,265,000 |
| cost of service and other revenue | 7,372,000 | 8,207,000 | 6,368,000 | 6,125,000 | 6,222,000 | 4,684,000 | 3,793,000 | 3,557,000 | 2,998,000 | 3,372,000 | 2,846,000 | 2,087,000 | 2,050,000 | 1,913,000 | 1,617,000 |
| total cost of revenue | 19,953,000 | 22,795,000 | 23,205,000 | 28,337,000 | 27,039,000 | 26,734,000 | 23,425,000 | 21,275,000 | 26,108,000 | 24,831,000 | 23,372,000 | 24,164,000 | 22,627,000 | 16,830,000 | 18,882,000 |
| gross profit | 8,215,000 | 7,712,000 | 7,157,000 | 7,703,000 | 6,428,000 | 5,273,000 | 4,336,000 | 3,782,000 | 4,442,000 | 3,321,000 | 2,946,000 | 1,052,000 | 289,000 | 417,000 | -5,126,000 |
| yoy | 27.80% | 46.25% | 65.06% | 103.68% | 44.71% | 58.78% | 47.18% | 259.51% | 1437.02% | 696.40% | -157.47% | ||||
| qoq | 6.52% | 7.75% | -7.09% | 19.84% | 21.90% | 21.61% | 14.65% | -14.86% | 33.75% | 12.73% | 180.04% | 264.01% | -30.70% | -108.13% | |
| gross margin % | 29.16% | 25.28% | 23.57% | 21.37% | 19.21% | 16.47% | 15.62% | 15.09% | 14.54% | 11.80% | 11.19% | 4.17% | 1.26% | 2.42% | -37.26% |
| operating expenses: | |||||||||||||||
| research and development | 12,635,000 | 12,532,000 | 16,076,000 | 14,906,000 | 13,793,000 | 11,444,000 | 13,059,000 | 13,521,000 | 10,831,000 | 11,410,000 | 9,729,000 | 8,032,000 | 7,570,000 | 7,784,000 | 9,175,000 |
| sales and marketing | 21,048,000 | 22,194,000 | 24,720,000 | 24,985,000 | 24,333,000 | 23,631,000 | 22,276,000 | 23,198,000 | 20,377,000 | 22,991,000 | 15,726,000 | 13,204,000 | 13,149,000 | 15,198,000 | 13,344,000 |
| general and administrative | 11,444,000 | 10,339,000 | 11,815,000 | 11,290,000 | 11,787,000 | 10,022,000 | 10,000,000 | 10,784,000 | 9,709,000 | 9,719,000 | 7,629,000 | 9,722,000 | 9,246,000 | 9,050,000 | 13,088,000 |
| total operating expenses | 45,127,000 | 45,065,000 | 52,611,000 | 51,181,000 | 49,913,000 | 45,097,000 | 45,335,000 | 47,503,000 | 40,917,000 | 44,120,000 | 33,084,000 | 30,958,000 | 29,965,000 | 32,032,000 | 35,607,000 |
| income from operations | -36,912,000 | -37,353,000 | -45,454,000 | -43,478,000 | -43,485,000 | -39,824,000 | -40,999,000 | -43,721,000 | -36,475,000 | -40,799,000 | -30,138,000 | -29,906,000 | -29,676,000 | -31,615,000 | -40,733,000 |
| yoy | -15.12% | -6.20% | 10.87% | -0.56% | 19.22% | -2.39% | 36.04% | 46.19% | 22.91% | 29.05% | -26.01% | ||||
| qoq | -1.18% | -17.82% | 4.54% | -0.02% | 9.19% | -2.87% | -6.23% | 19.87% | -10.60% | 35.37% | 0.78% | 0.78% | -6.13% | -22.38% | |
| operating margin % | -131.04% | -122.44% | -149.71% | -120.64% | -129.93% | -124.42% | -147.69% | -174.49% | -119.39% | -144.92% | -114.51% | -118.60% | -129.50% | -183.31% | -296.11% |
| interest income and other income | 3,098,000 | 2,282,000 | 2,573,000 | 2,668,000 | 2,648,000 | 1,907,000 | 805,000 | 459,000 | 120,000 | 123,000 | 99,000 | 164,000 | 112,000 | 2,000 | -3,000 |
| interest expense | -5,968,000 | -3,417,000 | -3,213,000 | -3,103,000 | -2,942,000 | -2,096,000 | -567,000 | -481,000 | -422,000 | -431,000 | -431,000 | -431,000 | -422,000 | -430,000 | -428,000 |
| income before benefit from income taxes | -39,782,000 | -38,488,000 | -46,094,000 | -43,913,000 | -43,779,000 | -41,380,000 | -40,761,000 | -43,743,000 | -36,777,000 | -41,107,000 | -30,470,000 | -30,173,000 | -29,986,000 | -32,043,000 | -42,294,000 |
| benefit from income taxes | 162,000 | 112,000 | 86,000 | 133,000 | 192,000 | 64,000 | 20,000 | 96,000 | 115,000 | 125,000 | 35,000 | 39,000 | |||
| net income | -39,944,000 | -38,600,000 | -46,180,000 | -44,046,000 | -43,971,000 | -41,444,000 | -40,781,000 | -43,839,000 | -36,892,000 | -41,232,000 | -30,470,000 | -30,208,000 | -30,025,000 | -32,043,000 | -42,294,000 |
| yoy | -9.16% | -6.86% | 13.24% | 0.47% | 19.19% | 0.51% | 33.84% | 45.12% | 22.87% | 28.68% | -27.96% | ||||
| qoq | 3.48% | -16.41% | 4.84% | 0.17% | 6.10% | 1.63% | -6.98% | 18.83% | -10.53% | 35.32% | 0.87% | 0.61% | -6.30% | -24.24% | |
| net income margin % | -141.81% | -126.53% | -152.10% | -122.21% | -131.39% | -129.48% | -146.90% | -174.96% | -120.76% | -146.46% | -115.78% | -119.80% | -131.02% | -185.79% | -307.46% |
| net income per share | -0.78 | -0.76 | -0.93 | -0.9 | -0.9 | -0.84 | -0.85 | -0.92 | -0.78 | -0.93 | -0.65 | -0.66 | 1.45 | -3.44 | |
| shares used in computing net income per share, basic and diluted | 50,901 | 224 | 49,913 | 48,951 | 48,783 | 326 | 48,129 | 47,882 | 47,487 | ||||||
| change in fair value of redeemable convertible preferred stock warrant liability | 437,000 | ||||||||||||||
| loss on extinguishment of term loan | -1,567,000 | ||||||||||||||
| net income attributable to common stockholders, basic and diluted | -41,232,000 | -30,470,000 | -30,208,000 | -32,043,000 | -42,294,000 | ||||||||||
| weighted-average shares used for eps calculation | 45,589 | 46,588 | 45,680 | 16,358 | 12,299 | ||||||||||
| net income attributable to common stockholders: | |||||||||||||||
| basic | -30,025,000 | ||||||||||||||
| diluted | -30,025,000 | ||||||||||||||
| net income per share | -0.78 | -0.76 | -0.93 | -0.9 | -0.9 | -0.84 | -0.85 | -0.92 | -0.78 | -0.93 | -0.65 | -0.66 | 1.45 | -3.44 | |
| basic | -0.7 | ||||||||||||||
| diluted | -0.7 | ||||||||||||||
| weighted-average shares used for eps calculation | 45,589 | 46,588 | 45,680 | 16,358 | 12,299 | ||||||||||
| basic | 42,760 | ||||||||||||||
| diluted | 42,760 |
We provide you with 20 years income statements for Outset Medical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Outset Medical stock. Explore the full financial landscape of Outset Medical stock with our expertly curated income statements.
The information provided in this report about Outset Medical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.